AI-generated summary
The authors reviewed eight papers on combining bright light with melatonin for sleep and circadian outcomes. In healthy participants, combined therapy advanced the circadian phase more than either treatment alone but did not outperform single therapy for delaying it. In older adults with cognitive decline, combined therapy was more beneficial than single therapy for sleep, while it showed no benefit in people with delayed sleep-wake phase disorder.
- Studies included
- 8
- Who or what was studied
- Healthy participants, elderly people with cognitive decline, and patients with delayed sleep-wake phase disorder
- Limits stated in the abstract
- The abstract reports only a small set of eight included papers and does not state their sample sizes, and it notes that melatonin's adverse effects in elderly populations must be carefully considered.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Systematic review, Cognitive decline. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.